Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-13 5:02 pm Sale | 13G | Lyell Immunopharma, Inc. LYEL | Foresite Capital Fund IV L.P. | 10,000,000 4% | -3,282,181 (-24.71%) | View |
| 2023-02-09 11:25 am Purchase | 13G | Lyell Immunopharma, Inc. LYEL | VANGUARD GROUP INC | 12,591,230 5.05% | 12,591,230 (New Position) | View |
| 2022-02-14 4:17 pm Purchase | 13G | Lyell Immunopharma, Inc. LYEL | MWG Management Ltd. | 20,162,332 8.38% | 20,162,332 (New Position) | View |
| 2022-02-14 4:10 pm Purchase | 13G | Lyell Immunopharma, Inc. LYEL | NEWTON (PTC) Ltd | 15,093,969 6.28% | 15,093,969 (New Position) | View |
| 2022-02-14 12:04 pm Purchase | 13G | Lyell Immunopharma, Inc. LYEL | ARCH Venture Fund IX L.P. | 36,412,716 15.1% | 36,412,716 (New Position) | View |
| 2022-02-11 3:10 pm Purchase | 13G | Lyell Immunopharma, Inc. LYEL | Foresite Capital Fund IV L.P. | 13,282,181 5.5% | 13,282,181 (New Position) | View |
| 2022-02-10 4:51 pm Purchase | 13G | Lyell Immunopharma, Inc. LYEL | GSK PLC | 30,253,189 12.6% | 30,253,189 (New Position) | View |